RENVELA

Identification of Renvela

No description

Google image searchProduct monograph

Active ingredient

sevelamer carbonate, 800 MG

DIN: 02354586

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: SANOFI-AVENTIS CANADA INC

Date: 24-JUL-2014

ATC:

• V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
• V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
• V03AE — Drugs for treatment of hyperkalemia and hyperphosphatemia (ATC, ATC/DDD)
• V03AE02 — SEVELAMER (ATC/DDD)

Reference brand drug: Renagel, Renvela

Pharmaceutical standard: MFR

External Links for Renvela

Search on Google

• Renvela side effects
• Renvela dosage
• sevelamer carbonate side effects
• sevelamer carbonate dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find renvela photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.